← Leaderboards
Chao Lu
New York University School Of Medicine
$7,221,423
Attributed
$9,785,409
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2016–25$2.5M$1.9M$1.3M$625K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,785,409 · 8
By mechanism
R01$6,235,633 · 3
R35$2,025,000 · 1
R00$686,081 · 1
T32$398,471 · 1
K99$275,724 · 1
R56$164,500 · 1
Top collaborators
- Karim Jean Armache4 shared
- Jianwen Que4 shared
- Swarnali Acharyya1 shared
- Alberto Ciccia1 shared
- Zhiguo Zhang1 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Karim Jean Armache$5,787,616
- Devin Michael Bready$142,253
- Thales Papagiannakopoulos$8,767,709
Others in their field
Top investigators on “Chromatin”
- Michael P Snyder · Yale University$98,050,605
- Bing Ren · Ludwig Institute For Cancer Research$76,818,585
- John A Stamatoyannopoulos · Regulome Corporation$56,022,526
- Bradley E Bernstein · Brigham And Women'S Hospital$44,846,223
- Eric J Nestler · Icahn School Of Medicine At Mount Sinai$42,440,927
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$40,714,772
Research focus
ChromatinMediatingMolecularGeneticHistonesMethylationInsightDna Modification MethylasesMutationEpigenetic ProcessRecurrenceGenome-WideEpigenomicsRecruitMalignant NeoplasmsGenomeMethyltransferaseEpigenetic RegulationBiologyEnzymesHuman DiseaseDna MethylationHistone H3Mouse Model
Grant awards (24)
Cell Fate Regulation in Esophageal Progenitor Cells$586,924
R01 · FY2025 · DK
Molecular basis for aberrant de novo DNA methylation in cancer$532,409
R01 · FY2025 · CA
Epigenetic Regulation of Head and Neck Cancer Immune Evasion$453,476
R01 · FY2025 · DE · contact PI
Genome and Epigenome Integrity In Cancer$398,471
T32 · FY2025 · CA
Cell Fate Regulation in Esophageal Progenitor Cells$563,447
R01 · FY2024 · DK
Molecular basis for aberrant de novo DNA methylation in cancer$505,789
R01 · FY2024 · CA
Epigenetic Regulation of Head and Neck Cancer Immune Evasion$444,406
R01 · FY2024 · DE · contact PI
Regulation and Function of Histone H3K36 Methylation in Mammalian Chromatin$405,000
R35 · FY2024 · GM · contact PI
Mechanisms of S100A9-mediated brain metastasis$164,500
R56 · FY2024 · CA
Cell Fate Regulation in Esophageal Progenitor Cells$586,924
R01 · FY2023 · DK
Molecular basis for aberrant de novo DNA methylation in cancer$521,760
R01 · FY2023 · CA
Epigenetic Regulation of Head and Neck Cancer Immune Evasion$453,476
R01 · FY2023 · DE · contact PI
Regulation and Function of Histone H3K36 Methylation in Mammalian Chromatin$405,000
R35 · FY2023 · GM · contact PI
Cell Fate Regulation in Esophageal Progenitor Cells$585,141
R01 · FY2022 · DK
Molecular basis for aberrant de novo DNA methylation in cancer$549,784
R01 · FY2022 · CA
Epigenetic Regulation of Head and Neck Cancer Immune Evasion$452,097
R01 · FY2022 · DE · contact PI
Regulation and Function of Histone H3K36 Methylation in Mammalian Chromatin$405,000
R35 · FY2022 · GM · contact PI
Regulation and Function of Histone H3K36 Methylation in Mammalian Chromatin$405,000
R35 · FY2021 · GM · contact PI
Regulation and Function of Histone H3K36 Methylation in Mammalian Chromatin$405,000
R35 · FY2020 · GM · contact PI
NSD1 Inactivation in Head and Neck Cancer$249,000
R00 · FY2020 · CA · contact PI
NSD1 Inactivation in Head and Neck Cancer$188,081
R00 · FY2019 · CA · contact PI
NSD1 Inactivation in Head and Neck Cancer$249,000
R00 · FY2018 · CA · contact PI
NSD1 Inactivation in Head and Neck Cancer$137,862
K99 · FY2017 · CA · contact PI
NSD1 Inactivation in Head and Neck Cancer$137,862
K99 · FY2016 · CA · contact PI